BioMarin Pharmaceutical Inc. buy Wells Fargo & Company
Start price
25.04.24
/
50%
€77.00
Target price
25.04.25
€102.63
Performance (%)
-8.65%
Price
15:54
€70.34
Summary
This prediction is currently active. With a performance of -8.65%, the BUY prediction by Wells_Fargo___Compan is trending in the wrong direction. This prediction currently runs until 25.04.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
BioMarin Pharmaceutical Inc. | -7.012% |
iShares Core DAX® | -0.051% |
iShares Nasdaq 100 | 1.659% |
iShares Nikkei 225® | 0.658% |
iShares S&P 500 | 0.964% |
Comments by Wells_Fargo___Compan for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Wells Fargo & Company from $100.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.32
15.11.23
15.11.23
€92.05
15.11.24
15.11.24
-12.43%
15:54
15:54